pharma news today glp-1 2025 Receptor Agonist Market Growth Analysis GLP-1 Agonists Weight Loss Drugs

Huge congratulations to the authors!

Note the launch of LillyDirect as an example of a branded, regulated pharmaceutical company going direct-to-consumer (DTC) beyond advertising to provide a service platform focused on obesity and weight management

Additionally, it will highlight the recent advances and ongoing challenges in the field of drug discovery related to GLP-1 receptor agonists.

Analizamos el impacto de los agonistas del GLP-1 en el trnsito intestinal, su prevalencia en pacientes con obesidad y pautas para el manejo del estreimiento

Many patients wonder if GLP-1 medications like semaglutide interact with oral contraceptives